Healthy Infants Clinical Trial
Official title:
Safety and Efficacy of Starter Infant Formula, Follow-up Formula and Growing-up Milk Supplemented With Pre- and Probiotic(s): a Double-blind, Randomized, Controlled Trial
This is a randomized, controlled, multicenter, double-blind study of healthy term infants. The primary objective of the trial is to demonstrate the safety of a a starter infant formula supplemented with pre- and probiotic(s) by comparing the growth of infants randomized to the experimental formula versus the control formula from enrolment to 4 months of age.
This is a randomized, controlled, multicenter, double-blind study of healthy term infants, consisting of two randomized formula-fed arms (control and experimental formulas) and a non-randomized breast-fed reference group. The population under investigation are healthy infants aged ≤14 days at enrollment. The planned sample size for formula-fed infants is 236 (118 per study group). A non-randomized breastfed reference group of 90 healthy, term, exclusively breastfed infants up to 4 months will also be enrolled. Study formulas are administrated orally, ad libitum, from enrollment until 15 months of age. The primary objective of the trial is to demonstrate the safety of a starter infant formula supplemented with pre- and probiotic(s) by comparing the growth (weight gain, g/day) of infants randomized to the experimental formula versus the control formula from enrolment to 4 months of age. In addition fecal microbiome, fecal metabolic profile, fecal markers of immune and gut health, blood markers of immune health (in a subset of 60 infants/group), GI tolerance, bone index (subset of 40 infants/group), other anthropometric measurements, dietary pattern and infant illness and infection outcomes will be assessed/measured. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03679234 -
Impact of Infant Formula on Caregiver-perceived Intolerance
|
N/A | |
| Completed |
NCT01681355 -
Gastrointestinal Tolerance Study of a New Infant Formula
|
N/A | |
| Completed |
NCT03722550 -
Second Generation Human Milk Oligosaccharides Blend Study
|
N/A | |
| Completed |
NCT03703583 -
Infant Feeding Practice and Gut Comfort Study
|
||
| Completed |
NCT01515644 -
Study on the Effect of Inulin in Infant Formula on Gut Health
|
Phase 3 | |
| Completed |
NCT03014115 -
Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Infection Rates in Infants
|
N/A | |
| Recruiting |
NCT06053112 -
The Trial of a New Infant Formula in Healthy Term Chinese Infants
|
N/A | |
| Completed |
NCT03000543 -
Novel Isotope Dilution Technique to Assess Vitamin A Status
|
N/A | |
| Not yet recruiting |
NCT06361719 -
Efficacy of Two HMOs in Chinese Infants
|
N/A | |
| Terminated |
NCT03976596 -
Measurement of in Vivo Mitochondrial Capacity in Infants
|
||
| Recruiting |
NCT01601197 -
A Study of Two Injection Techniques to Reduce Pain in Infants Undergoing Immunization
|
Phase 3 | |
| Completed |
NCT01635816 -
Immunogenicity of SA 14-14-2 JE Vaccine
|
Phase 4 | |
| Completed |
NCT01633216 -
Poliovirus Vaccine Trial in Bangladesh
|
Phase 4 | |
| Completed |
NCT00957892 -
Effects of Infant Formula Composition on Infant Feeding Behaviors
|
N/A | |
| Completed |
NCT03801161 -
Influence of Inflammation on Micronutrient Status Assessment
|
N/A | |
| Active, not recruiting |
NCT06073652 -
Starter Infant Formula With Synbiotics
|
N/A | |
| Completed |
NCT01825109 -
Improving Rotavirus Vaccine Immune Response
|
Phase 3 | |
| Withdrawn |
NCT01507935 -
Colonisation Resistance Study
|
Phase 2 | |
| Completed |
NCT01594840 -
Changing Chat: Diaper Tips to Improve Language Development
|
N/A | |
| Not yet recruiting |
NCT01249911 -
Lactobacillus Reuteri DSM 17938 and Prevention of Respiratory and Gastrointestinal Infections in Mexican Infants
|
Phase 3 |